The trajectory of Viagra presents a intricate picture for shareholders. While the initial release generated significant profits, the lapse of its exclusive rights opened the floodgates to off-brand alternatives, https://apollobookmarks.com/story21573793/sildenafil-and-big-pharma-a-volatile-investment